Your browser doesn't support javascript.
loading
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis.
Achleitner, Martin; Steenblock, Charlotte; Dänhardt, Juliane; Jarzebska, Natalia; Kardashi, Romina; Kanczkowski, Waldemar; Straube, Richard; Rodionov, Roman N; Bornstein, Nitzan; Tselmin, Sergey; Kaiser, Frank; Bucher, Ronald; Barbir, Mahmoud; Wong, Ma-Li; Voit-Bak, Karin; Licinio, Julio; Bornstein, Stefan R.
Afiliação
  • Achleitner M; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Steenblock C; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. charlotte.steenblock@uniklinikum-dresden.de.
  • Dänhardt J; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Jarzebska N; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Kardashi R; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Kanczkowski W; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Straube R; Zentrum für Apherese- und Hämofiltration am INUS Tageklinikum, Cham, Germany.
  • Rodionov RN; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bornstein N; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Tselmin S; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Kaiser F; Alpstein Clinic, Gais, Switzerland.
  • Bucher R; Biologicum Baden-Baden INUSpherese Zentrum, Baden-Baden, Germany.
  • Barbir M; Department of Cardiology, Harefield Hospital, Harefield, United Kingdom.
  • Wong ML; Department of Psychiatry and Behavioral Sciences, College of Medicine, State University of New York (SUNY) Upstate Medical University, Syracuse, NY, USA.
  • Voit-Bak K; Department of Neuroscience & Physiology, College of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Licinio J; Zentrum für Apherese- und Hämofiltration am INUS Tageklinikum, Cham, Germany.
  • Bornstein SR; Department of Psychiatry and Behavioral Sciences, College of Medicine, State University of New York (SUNY) Upstate Medical University, Syracuse, NY, USA.
Mol Psychiatry ; 28(7): 2872-2877, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37131073

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Remoção de Componentes Sanguíneos / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Remoção de Componentes Sanguíneos / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article